Peggy Hours-Zesiger

Initial combination therapy with vildagliptin plus metformin in drug-naïve patients with T2DM: a 24-week real-life study from Asia

Roberto C. Mirasol, M. Chawla, Tae Ho Kim, 2018, Current medical research and opinion.

Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial

U. Reuter, C. Hentschke, A. Gendolla, 2021, Cephalalgia : an international journal of headache.

Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study

Shuu-Jiun Wang, A. Roxas, N. Riachi, 2021, Cephalalgia : an international journal of headache.

Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study

M. Ferrari, P. Goadsby, U. Reuter, 2018, The Lancet.

Long-term Efficacy and Safety of Erenumab

M. Ferrari, P. Goadsby, U. Reuter, 2021, Neurology.

Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2–4 preventives were not useful: results from the LIBERTY study

M. Ferrari, P. Goadsby, U. Reuter, 2021, Journal of Neurology, Neurosurgery, and Psychiatry.